Reliability and validity of the post COVID-19 condition stigma questionnaire: A prospective cohort study

被引:8
|
作者
Damant, Ronald W. [1 ]
Rourke, Liam [1 ]
Cui, Ying [2 ]
Lam, Grace Y. [1 ]
Smith, Maeve P. [1 ]
Fuhr, Desi P. [1 ]
Tay, Jaqueline K. [1 ]
Varughese, Rhea A. [1 ]
Laratta, Cheryl R. [1 ]
Lau, Angela [1 ]
Wong, Eric Y. [1 ]
Stickland, Michael K. [1 ]
Ferrara, Giovanni [1 ]
机构
[1] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada
[2] Univ Alberta, Fac Educ, Edmonton, AB, Canada
关键词
Long COVID; Post COVID-19 condition; PCC; Post-acute sequelae of COVID-19; SARS-CoV-2; Stigma; Health related stigma; Stigmatization; Stigma as a social determinant of health; SCALE;
D O I
10.1016/j.eclinm.2022.101755
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Many of the 10-20% percent of COVID-19 survivors who develop Post COVID-19 Condition (PCC, or Long COVID) describe experiences suggestive of stigmatization, a known social determinant of health. Our objective was to develop an instrument, the Post COVID-19 Condition Stigma Questionnaire (PCCSQ), with which to quantify and characterise PCC-related stigma. Methods We conducted a prospective cohort study to assess the reliability and validity of the PCCSQ. Patients referred to our Post COVID-19 Clinic in the Canadian City of Edmonton, Alberta between May 29, 2021 and May 24, 2022 who met inclusion criteria (attending an academic post COVID-19 clinic; age >= 18 years; persistent symptoms and impairment at >= 12 weeks since PCR positive acute COVID-19 infection; English-speaking; internet access; consenting) were invited to complete online questionnaires, including the PCCSQ. Analyses were conducted to estimate the instrument's reliability, construct validity, and association with relevant instruments and defined health outcomes. Findings Of the 198 patients invited, 145 (73%) met inclusion criteria and completed usable questionnaires. Total Stigma Score (TSS) on the PCCSQ ranged from 40 to 174/200. The mean (SD) was 103.9 (31.3). Cronbach's alpha was 0.97. Test-retest reliability was 0.92. Factor analysis supported a 6-factor latent construct. Subtest reliabilities were >0.75. Individuals reporting increased TSS occurred across all demographic groups. Increased risk categories included women, white ethnicity, and limited educational opportunities. TSS was positively correlated with symptoms, depression, anxiety, loneliness, reduced self-esteem, thoughts of self-harm, post-COVID functional status, frailty, EQ5D5L score, and number of ED visits. It was negatively correlated with perceived social support, 6-min walk distance, and EQ5D5L global rating. Stigma scores were significantly increased among participants reporting employment status as disabled. Interpretation Our findings suggested that the PCCSQ is a valid, reliable tool with which to estimate PCC-related stigma. It allows for the identification of patients reporting increased stigma and offers insights into their experiences. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Development of the COVID-19 Stigma Scale: Validity and Reliability Study
    Geni, Bahadir
    Yildiz, Mustafa
    GAZI MEDICAL JOURNAL, 2024, 35 (02): : 121 - 131
  • [2] Reliability and Validity of the Perception of Stigma due to COVID-19 in Physicians
    Oktar, Didem
    Gedik, S. Aydogan
    Sungur, S.
    Onsuz, M. F.
    Metintas, S.
    Kosger, F.
    Altinoz, A. E.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31 : 275 - 275
  • [3] The Turkish Adaptation of the COVID-19 Perinatal Perception Questionnaire: Validity and Reliability Study
    Abay, Halime
    Guelmez, Beguem oeZTueRK
    Kaplan, Sena
    BEZMIALEM SCIENCE, 2024, 12 (01): : 15 - 23
  • [4] Post COVID-19 condition among adults in Malaysia following the Omicron wave: A prospective cohort study
    Tok, Peter Seah Keng
    Kang, Kong Yeow
    Ng, Sock Wen
    Ab Rahman, Norazida
    Syahmi, Muhammad Aminul
    Pathmanathan, Mohan Dass
    Appannan, Maheshwara Rao
    Peariasamy, Kalaiarasu M.
    Sivasampu, Sheamini
    PLOS ONE, 2024, 19 (01):
  • [5] Post COVID-19 syndrome in a prospective cohort study of Egyptian patients
    Dalia Mohamed Gamal
    Rehab Ali Ibrahim
    Sara Farid Samaan
    Egyptian Rheumatology and Rehabilitation, 2022, 49
  • [6] Post COVID-19 syndrome in a prospective cohort study of Egyptian patients
    Gamal, Dalia Mohamed
    Ibrahim, Rehab Ali
    Samaan, Sara Farid
    EGYPTIAN RHEUMATOLOGY AND REHABILITATION, 2022, 49 (01)
  • [7] Dysphagia in post Covid-19 Patients- a Prospective Cohort Study
    Sharma, Priyam
    Khaund, Gautam
    Agarwal, Vivek
    Barman, Surajit
    Baruah, Debika
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2023, 75 (02) : 463 - 468
  • [8] Dysphagia in post Covid-19 Patients- a Prospective Cohort Study
    Priyam Sharma
    Gautam Khaund
    Vivek Agarwal
    Surajit Barman
    Debika Baruah
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2023, 75 : 463 - 468
  • [9] Clinical and serological predictors of post COVID-19 condition-findings from a Canadian prospective cohort study
    Collins, Erin
    Galipeau, Yannick
    Arnold, Corey
    Bhereur, Anne
    Booth, Ronald
    Buchan, Arianne C.
    Cooper, Curtis
    Crawley, Angela M.
    McCluskie, Pauline S.
    McGuinty, Michaeline
    Pelchat, Martin
    Rocheleau, Lynda
    Saginur, Raphael
    Gravel, Chris
    Hawken, Steven
    Langlois, Marc-Andre
    Little, Julian
    FRONTIERS IN PUBLIC HEALTH, 2024, 12
  • [10] Longitudinal clinical phenotyping of post COVID condition in Mexican adults recovering from severe COVID-19: a prospective cohort study
    Nunez, Isaac
    Gillard, Joshua
    Fragoso-Saavedra, Sergio
    Feyaerts, Dorien
    Islas-Weinstein, Leon
    Gallegos-Guzman, Angel A.
    Valente-Garcia, Uriel
    Meyerowitz, Justin
    Kelly, J. Daniel
    Chen, Han
    Ganio, Edward
    Benkendorff, Alexander
    Flores-Gouyonnet, Jaime
    Dammann-Beltran, Pedro
    Heredia-Gonzalez, Jose Francisco
    Rangel-Gutierrez, Gabriela A.
    Blish, Catherine A.
    Nadeau, Kari C.
    Nolan, Garry
    Crispin, Jose C.
    Mcilwain, David R.
    Gaudilliere, Brice
    Valdes-Ferrer, Sergio I.
    FRONTIERS IN MEDICINE, 2023, 10